CJC1295 No DAC


CJC-1295 No DAC

CJC-1295 No DAC (No Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to naturally stimulate the pituitary gland’s production of growth hormone (GH). It does this by mimicking GHRH activity and triggering powerful GH pulses—without remaining in circulation for extended periods like the DAC version. This shorter half-life closely mimics the body’s natural growth hormone rhythm, resulting in a more efficient and biologically aligned peptide therapy.

CJC No DAC has been shown to increase GH levels by up to 200–1000%, making it a powerful alternative to exogenous hGH, but without the drawbacks of suppression or long-term adaptation. It’s favored for fat loss, muscle recovery, anti-aging, and regenerative benefits.


Key Benefits

  • Stimulates lean muscle growth and recovery
  • Reduces adipose (fat) tissue
  • Increases bone density and skeletal strength
  • Promotes collagen synthesis (skin, joints, connective tissue)
  • Improves sleep cycles and circadian rhythm
  • Enhances energy levels and vitality
  • Strengthens the immune system
  • Accelerates connective tissue repair (tendons, ligaments)

Mechanism of Action

CJC-1295 No DAC acts on:

  • Growth Hormone Pathways: Triggers GH pulses from the pituitary gland
  • IGF-1 & LR3IGF-1: Elevates downstream markers responsible for muscle hypertrophy and regeneration
  • Albumin Binding & Circulation: Designed for rapid absorption and release (30 min half-life), avoiding desensitization

This short-duration activity prevents receptor downregulation and mimics how GH is naturally secreted in healthy individuals, especially during deep sleep and fasting.


Regenerative & Systemic Benefits

  • Boosts B and T-cell count in aging and immunocompromised individuals
  • Increases antibody production, improving immune resilience
  • Supports stem cell regeneration after organ or tissue damage
  • Stimulates pancreatic cell proliferation
  • May help repair cardiac tissue after heart attacks
  • Enhances fertility and libido, especially in older adults
  • Reduces triglycerides and supports cardiovascular health through improved body composition
  • Shown to support cognition after neurological injury

CJC-1295 No DAC vs DAC Version

The primary difference between CJC No DAC and CJC DAC is the duration of action:

  • CJC DAC: 6–8 day half-life, constant systemic exposure, may lead to desensitization over time
  • CJC No DAC: 30-minute half-life, pulsed GH release, prevents adaptation, more closely mirrors natural GH production

CJC No DAC is preferred for longer-term use and bioidentical GH optimization.


Stacking with Ipamorelin

CJC-1295 No DAC is frequently stacked with Ipamorelin, a selective GH secretagogue that triggers additional GH pulses through a different pathway. When used together, the combo dramatically amplifies growth hormone output—leading to better muscle repair, fat loss, and recovery.

  • Both are administered simultaneously, often twice or three times per day for optimal synergy
  • This stack is safer and more effective than other GHRP combinations

Possible Side Effects

Common:

  • Redness or irritation at injection site
  • Temporary water retention
  • Increased appetite
  • Mild fatigue
  • Flushing or warmth
  • Light-headedness or dizziness
  • Headache or nausea
  • Digestive upset (bloating, diarrhea)
  • Tingling sensations
  • Mild hyperactivity or jitteriness

Rare:

  • Temporary increase in blood pressure or pulse
  • Hives or allergic skin reactions

Side Effect Management

  • Start low, go slow: Gradually increase dosing over time
  • Hydrate aggressively to manage water retention
  • Use magnesium to counter water retention naturally
  • For persistent side effects, consult a physician

Contraindications

Do NOT use CJC-1295 No DAC (alone or with Ipamorelin) if:

  • You are pregnant or breastfeeding
  • You are currently using other GH secretagogues or growth hormone supplements
  • You have active cancer, untreated cardiovascular conditions, or hormonal disorders
  • You are hypersensitive to peptide-based medications

Dosing Protocol

CJC-1295 NO DAC: 10MG – RECONSTITUTION AND DOSING

Subcutaneous Administration

.3mL/cc (30-unit) or .5mL/cc (50-unit) syringes recommended


Low-Dose Protocol (General Benefits / Anti-Aging / Women)

  • Weeks 1–4 (or 1–6): 3 units (100mcg), once daily
  • Weeks 5–12: 5 units (150mcg), once daily

2x/Day Protocol (Muscle Tone, Mild Recovery)

  • Week 1: 3 units (100 mcg), 2x/day
  • Weeks 2–4 (or 2–6): 5 units (200 mcg), 2x/day
  • Weeks 5–8 (or 7–12): 8 units (300 mcg), 2x/day

3x/Day Protocol (Athletes / Bodybuilders / Max Recovery)

  • Days 1–3: 4 units (150 mcg), 3x/day
  • Days 4–7: 5 units (200 mcg), 3x/day
  • Weeks 2–3: 8 units (300 mcg), 3x/day
  • Weeks 4–6: 10 units (400 mcg), 3x/day
  • Weeks 7–12: 13 units (500 mcg), 3x/day

STACKING SUGGESTIONS

To maximize results and drive more conversions:

  • Ipamorelin – Boosts GH secretion through synergistic action
  • TB-500 / BPC-157 – For injury recovery, tissue regeneration, and joint health
  • AOD-9604 – Supports fat metabolism without muscle loss
  • GHK-Cu – Skin and tissue repair, anti-aging benefits
  • Glutathione – Cellular detox, immune support

Are you satisfied with this article? Usefulness of the article: 0 / 0

FAQs From Same Category

5-Amino 1MQ

5-Amino-1MQ is a small molecule compound designed to inhibit the enzyme NNMT (nicotinamide N-methyltransferase), which plays a key role in metabolic regulation and fat cell activity. By suppressing NNMT, 5-Amino-1MQ increases NAD⁺ levels and helps to accelerate energy metabolism, support healthy body composition, and reduce fat mass—especially visceral fat. It has gained attention for its potential to improve insulin sensitivity, mitochondrial function, and cellular repair, making it a popular option in fat loss, longevity, and athletic performance protocols.

  • Promotes rapid fat loss without muscle breakdown
  • Inhibits fat cell growth and reduces existing fat deposits
  • NAD+ preservation: NAD+ is essential for mitochondrial function, which is central to the production of energy (ATP) within cells. As we age, NAD+ levels naturally decline, which can impair cellular energy production and lead to aging-related diseases. 5-Amino-1MQ’s ability to inhibit CD38 and preserve NAD+ levels is of significant interest for anti-aging and longevity research.
  • Mitochondrial Biogenesis: 5-Amino-1MQ may also contribute to mitochondrial biogenesis, which refers to the generation of new mitochondria in cells. Mitochondria are responsible for energy production, and an increase in their numbers can improve overall cellular function and endurance.
  • Improves insulin sensitivity and glucose tolerance
  • Cognitive Health: By improving mitochondrial health and NAD+ levels, 5-Amino-1MQ may help protect brain cells from age-related neurodegenerative diseases like Alzheimer’s and Parkinson’s disease. NAD+ is essential for neuronal function and survival.
  • Increased Brain Energy: The compound’s potential to enhance mitochondrial function could improve energy metabolism in the brain, supporting cognitive performance and possibly reducing brain fatigue
  • Supports cellular longevity and anti-aging effects
  • Improved Endurance: By enhancing mitochondrial activity and fat oxidation, 5-Amino-1MQ could improve physical endurance and exercise capacity. This may be particularly beneficial for endurance athletes or anyone looking to increase their stamina.
  • May assist in reducing inflammation and oxidative stress
  • Muscle Preservation: Because 5-Amino-1MQ promotes fat loss rather than muscle loss, it may help maintain lean muscle mass while reducing body fat. This makes it an attractive option for individuals undergoing body composition changes.

5-Amino-1MQ works primarily by:

  • NNMT Inhibition: Suppresses the enzyme responsible for downregulating energy metabolism in fat cells
  • NAD⁺ Elevation: Increases intracellular NAD⁺, enhancing mitochondrial function and energy production
  • Mitochondrial Optimization: Promotes thermogenesis and lipid oxidation via improved mitochondrial efficiency

The result is an upregulation of cellular metabolism, reduced fat accumulation, and improved lean body mass.


Common (usually temporary and mild):

  • Headache
  • Mild fatigue
  • Digestive discomfort (bloating, nausea)
  • Mild increase in heart rate

Rare:

  • Skin irritation or redness at injection site
  • Dizziness or jitteriness
  • Temporary sleep disturbances

  • Stay hydrated and eat balanced meals during the protocol
  • Reduce dosage if fatigue or nausea occurs
  • Use smaller split doses if needed to increase tolerance

Do NOT use 5-Amino-1MQ if:

  • You are pregnant or breastfeeding
  • You have uncontrolled cardiovascular conditions
  • You have liver or kidney impairment
  • You are allergic to any excipients or BAC
  • You are on medications that alter NAD metabolism without physician oversight

4-8 week cycles followed by a 2-4 week washout period

May be taken any time of day, although morning or afternoon is preferred

Does not need to be taken while fasting, although GI side effects may be mitigated by dosing along with a light meal

Subcutaneous Administration


4-Week Minimum Protocol

  • Weeks 1-2: Take 20 units (1mg), 1x/day
  • Weeks 3-4: Take 40 units (2mg), 1x/day
  • Weeks 1-4: 20 units (1mg), 1x/day
  • Weeks 5-8: 40 units (2mg), 1x/day OR continue with 20 units (1mg) for duration of cycle

Standard Protocol (Recommended)

Mix with 2mL (200 units) of BAC water

  • Week 1: 20 units (1mg), 1x/day
  • Week 2-3: 40 units (2mg), 1x/day
  • Weeks 3-4: 60 units (3mg), 1x/day
  • Weeks 5-6: 80 units (4mg), 1x/day
  • Weeks 7-8: 100 units (5mg), 1x/day

4-6 week cycles followed by a 2-4 week washout period

May be taken any time of day, although morning or afternoon is preferred

Does not need to be taken while fasting; GI side effects may be mitigated by dosing along with a light meal

It is recommended to split the daily dose in to two or three injections to maintain a steady level of 5-Amino-1mq in the blood

Most effective when cycled at the start of a cutting period

Subcutaneous Administration


Recommended Protocol


Single Daily Dose Protocol


  • AOD-9604 – Targets fat loss with no muscle deterioration
  • CJC-1295 + Ipamorelin – Boosts growth hormone for enhanced metabolic effect
  • GLP-1 Agonists (Semaglutide, Tirzepatide) – Supports appetite suppression and insulin regulation
  • Glutathione or NAD+ Precursors – To amplify anti-aging and mitochondrial repair benefits

Are you satisfied with this article? Usefulness of the article: 0 / 0

Adamax
Adamax, a potent synthetic peptide analog of Semax developed by Russian researchers, is primarily known for its:
 

neuroprotective and cognitive-enhancing benefits. Its unique structure helps it cross the blood-brain barrier effectively, increasing its bioactive stability. 

  • Bacteriostatic water
  • Recommended insulin syringes for dosing: 1mL-30 gauge-8mm (5/16″) or .5mL-30 gauge-8mm (5/16″)

8-12 week cycle followed by washout period equal to the length of the cycle you completed

Daily Dosing

Morning dosing recommended, although not absolutely mandatory; try to be consistent with your dosing time each day

You do not have to be fasted to dose

Subcutaneous Administration



Weeks 1-2: Take 9 units (300mcg) once per day

Weeks 3-4: Take 15 units (500mcg) once per day

Weeks 5-6: Take 23 units (750mcg) once per day

Weeks 7-8+: Take 30 units (1,000mcg) once per day


Are you satisfied with this article? Usefulness of the article: 0 / 0

Adipotide

Adipotide (aka prohibitin-TP01 and fat-targeted proapoptotic peptide) designed to selectively eliminate blood vessels feeding white adipose (fat) tissue. It combines a homing sequence that targets fat-vasculature receptors (e.g. prohibitin/annexin A2) and a pro-apoptotic (cell death-inducing) sequence that triggers vessel cell death. The mechanism aims to starve fat cells of blood supply, leading to targeted fat tissue loss rather than systemic appetite suppression. Once the fat tissue has undergone apoptosis, it is cleared by the body. These results happen regardless of whether or not a person changes their diet or exercise regimens.

  • Targeted visceral fat reduction: Adipotide preferentially affected white adipose tissue, including visceral fat around organs. Visceral fat is linked to cardiovascular diseases, diabetes, and metabolic risk- reducing it can have outsized health benefits compared to losing general body weight.
  • Improved insulin support, for Type 2 diabetics
  • Because the targeting receptor, prohibitin, is also present in some tumor vasculature, it is of interest to cancer researchers
  • Its non-CNS peripheral action provides a mechanistic contrast to central appetite-modulating drugs

  • Injection site reactions (redness, swelling, and/or itching)
  • Loss of appetite
  • Fatigue
  • Dizziness
  • Electrolyte imbalance
  • Dehydration
  • Dose-dependent, predictable, reversible renal injury and tubular dysfunction, including minimal to moderate tubular degeneration and necrosis after treatment, typically resolved after treatment.
  • Increased urine output and slight dehydration have been observed, potentially reflecting early kidney function disruption
  • Serum creatinine elevation indicate kidney strain, although typically mild and reversible
  • Dehydration common, potentially linked to increased diuresis and kidney changes


  • Co-administration with other nephrotoxic agents (e.g. aminoglycosides, certain chemotherapeutics, high-dose contrast agents) could theoretically increase the risk of combined kidney toxicity.
  • Because Adipotide influences fat tissue metabolism and possibly insulin sensitivity, theoretical interactions with glucose-lowering medications (e.g. insulin or hypoglycemic agents) or lipid-modifying agents could occur, although no controlled data exist.

  • Do not use if pregnant or breastfeeding
  • Do not use if you have pre-existing renal impairment. Can be particularly hard on the kidneys.

28-day cycle followed by 12-28 day washout period

Daily dosing for duration of the cycle 

May be dosed at any time, day or night

Adipotide does not have to be taken in a fasted state

Subcutaneous administration: abdominal region recommended


Days 1-7: 8 units (.33mg), 1x/day

Days 9-14: 14 units (.55mg), 1x/day

Days 15-28: 25 units (1mg), 1x/day                


Are you satisfied with this article? Usefulness of the article: 0 / 0

AOD 9604

AOD-9604 is a fragment of the human growth hormone developed for the treatment of obesity. It is designed to mimic the fat-burning properties of hGH without its muscle-building effects or the common side effects.

This is achieved through Tyrosine (TYR), a portion of the amino acid sequence responsible for fat reduction and tissue repair. It mimics the effects of hGH on lipid metabolism without promoting growth or triggering pro-diabetic effects.

Where GLP-1 agonists suppress appetite and influence insulin secretion, AOD-9604 inhibits lipoprotein lipase activity in fat tissue, stimulating lipolysis in adipocytes. It specifically targets areas of the body with high fat deposits, preventing the conversion of carbohydrates into triglycerides and fatty acids and blocking the process of lipogenesis.

AOD-9604 can be particularly useful when stacked with GLP-1s to combat plateaus and target stubborn fat that diet and exercise alone may not eliminate.


  • Increases metabolism
  • Stimulates lipolysis
  • Inhibits lipogenesis (formation of fat cells)
  • Promotes bone and cartilage repair
  • Improves bone strength
  • Does not impact blood sugar levels
  • Enhances collagen production and skin elasticity
  • Possesses anti-inflammatory properties (beneficial for arthritis)
  • Enhances joint flexibility and mobility
  • Prevents medication-related muscle-wasting

  • Injection site reactions (redness, swelling, itching)
  • Headache
  • Fatigue
  • Dizziness
  • Cough
  • Chest tightness or constriction
  • Heart palpitations
  • Cold-like symptoms

Beta-adrenergic and fat-metabolism agents (e.g. clenbuterol, ephedrine, synephrine, stimulants): may produce palpitations and jitteriness


  • Do not use AOD-9604 if you are pregnant or breastfeeding
  • Do not use AOD-9604 if you are pregnant or breastfeeding
  • Do not take with an active malignancy
  • Because it is metabolized via proteolytic degradation and renal clearance, do not take AOD-9604 if you have severe liver or kidney disease
  • Discontinue use if you determine you are hypersensitive or allergIC

Do not use AOD-9604 if you are pregnant or breastfeeding.


Dose 1-2 times per day, daily

First dose should be in the morning while fasted, and second should be while fasted (at least 1.5 hours following and preceding a meal)

If at all possible, remain fasted 3-4 hours following injection

Subcutaneous Administration


We advise purchasing Acetic Acid solution from one of the links included below in order to combat gelling if it occurs. AOD-9604 has a tendency to be a fairly unstable peptide ( high-maintenance in peptide form, if you will)

WHERE CAN I BUY ACETIC ACID?

Bireiao, 30mL, $11.99

https://a.co/d/0iJSh6dH


Quality Research Chemicals, 10mL, $11.95

https://a.co/d/07DdB6Ob


Zoniuu, 10mL, $9.99

https://a.co/d/03jnopya


20 day cycle, followed by 10 day washout period; repeat for as long as necessary


Reconstitution


Dosing

Take 15 units (300mcg) once per day


FAT BURNING/WEIGHT LOSS PROTOCOL

90 day cycle, followed by 30 day washout period


Reconstitution


Dosing

Take 13 units (250mcg) twice per day: once immediately after waking and the second at least 1.5 hours after dinner


Stacking Suggestions

AOD-9604 stacks well with several peptides, especially for regenerative or fat-loss goals. Common combinations include:

  • GLP-1s
  • BPC-157
  • TB-500
  • Ipamorelin
  • Sermorelin
  • CJC No DAC

Are you satisfied with this article? Usefulness of the article: 0 / 0